Mein Warenkorb

GDNF

GDNF Molekülinformation

Englischer NameGlial cell line-derived neurotrophic factorsAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5Target-AliasGlial Cell Line-Derived Neurotrophic Factors
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Englischer NameGlial cell line-derived neurotrophic factors
Target-AliasGlial Cell Line-Derived Neurotrophic Factors
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5
Höchste Forschungs- und EntwicklungsphaseNDA/BLA

GDNF Produktliste

  • Attribut

    Protein (5)Kits (1)

  • Produktbibliothek

    Online (6)

  • Spezies

    Human (5)Mouse (1)

  • Etikett

    Tag Free (4)His Tag (1)- (1)

  • Marker

    Unconjugated (5)- (1)

GDNF Molekülhintergrund

Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake. GDNF is a glycosylated, disulfide-bonded homodimer that is a distantly related member of the transforming growth factor-beta superfamily. The GDNF family members (consists of GDNF, neurturin, artemin and persephin) are structurally similar to transforming growth factor-beta. Unlike other members of the TGF-beta superfamily, which signal through the receptor serine-threonine kinases, GDNF family ligands activate intracellular signalling cascades via the receptor tyrosine kinase Ret. GDNF family ligands binds to GDNF family receptor alpha (GFRalpha) and then the GDNF family ligand-GFR alpha complex binds to and stimulates autophosphorylation of Ret.

GDNF Molekülalias

GDNF,ATF

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
AB-1005AMT-140; AB-1005; AAV2-GDNF; AAV2-GDNF-MSA; AAV2-GDNF-PDPhase 2 ClinicalUc San FranciscoMultiple System Atrophy; Parkinson Disease
Details
NRO-1NRO-1; SI-01Phase 2 ClinicalSenju Pharmaceutical Co LtdXerophthalmia
Details
Ifezuntirgene inilparvovecAAV5-miSNP15; AMT-130; AAV5-miHtt12; AAV5-miSNP7Phase 2 ClinicalAmsterdam Molecular Therapeutics, UniqureHuntington Disease
Details
AAV2-GDNF gene therapy (NINDS)Phase 1 ClinicalNational Institute Of Neurological Disorders And StrokeParkinson Disease
Details
RGL-193RGL-193Phase 1 ClinicalShanghai Regenelead Therapies Co LtdParkinson Disease
Details

Produktrezensionen

  • P***i2025-05-13
    0Menschen mögen
    Acro Biosystems' GDNF recombinant protein has proven to be a reliable and high-quality reagent for research focused on neuronal development and maturation. In my study involving cortical projection neuron cultures, GDNF consistently supported neuronal survival, neurite outgrowth, and the expression of maturation markers. Its batch-to-batch consistency and biological activity have made it an essential component in our differentiation protocols. I highly recommend this product to laboratories engaged in both fundamental neuroscience research and translational studies aiming to model neurodegenerative diseases or explore neuroprotective strategies.
  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns